Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study

Kefah Mokbel¹, Munaser Almoodi^{1

2}

Affiliations

Comment

Kefah Mokbel et al. Br J Surg. 2023.

. 2023 Nov 9;110(12):1903.

doi: 10.1093/bjs/znad327.

Kefah Mokbel¹, Munaser Almoodi^{1

2}

No abstract available

Comment in

Author response to: Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study.
Gentile D, Tinterri C. Gentile D, et al. Br J Surg. 2023 Nov 9;110(12):1905. doi: 10.1093/bjs/znad329. Br J Surg. 2023. PMID: 37815150 Free PMC article. No abstract available.

Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group. Tinterri C, et al. Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215. Br J Surg. 2023. PMID: 37471574 Free PMC article. Clinical Trial.

1. Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona Aet al. . Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment. Br J Surg 2023;110:1143–1152 - PMC - PubMed